Dr. Reddy's gets USFDA Form 483 with 3 observations at Srikakulam unit

Regulatory & Legal View source PDF Explain this filing

DRREDDY · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹1143.00

prior close

₹1143.00

announcement price

After-mkt

timing

Nifty 100market+0.2%-0.1% vs market

Pharmaceuticals peers, median of 162sector-0.8%+0.9% vs sector

On the reaction day the stock moved 0.1 pts less than Nifty 100 and 0.9 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.3

10m

+0.2

15m

+0.1

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1+0.2-0.1-0.8+0.9

Next day

+0.4+0.7-0.3-0.5+1.0

+2.3+2.3+0.0+0.2+2.1

+2.6+1.6+1.0+0.1+2.5

+2.9+1.7+1.2+0.5+2.4

+2.4+1.8+0.7+0.4+2.0

+1.4+1.7-0.3+1.4-0.0

15d

+3.2+0.3+2.9+0.3+2.9

+1.0-0.3+1.3+1.7-0.7

+7.9-6.2+14.1+2.7+5.2

+18.3pendingpending-3.1+21.3

UpDownMarket · Nifty 100Sector · Pharmaceuticals peers, median of 162Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

USFDA completed a Pre-Approval Inspection and GMP inspection at Dr. Reddy's FTO-SEZ Process Unit-02 in Srikakulam, Andhra Pradesh from July 20 to 29, 2026. The company received a Form 483 with three observations, which it will address within the stipulated timeline. A Form 483 is issued when USFDA inspectors note conditions that may violate regulations. It is less serious than a Warning Letter and is often resolved through corrective action.

Likely market impact

Limited observations are generally manageable. Timely resolution matters to avoid escalation. Watch for product approvals from this unit.